Stay updated on Risankizumab Maintenance in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab Maintenance in Psoriasis Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 in the Study Documents, indicating a new version of documents is available. This reflects updated Protocol and Statistical Analysis Plan materials associated with the AbbVie study.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website’s ClinicalTrials.gov footer was updated from revision v3.5.2 to v3.5.3, indicating a platform release/version update.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded 'State of Vienna' as the location designation and updated Vienna addresses to 'Vienna, State of Vienna, Austria, 1030' and '1090', replacing the previous 'Vienna' entries. Also updated the page revision from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. The study details and page layout appear unchanged.SummaryDifference0.0%

- Check76 days agoChange Detected- Revision metadata updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Risankizumab Maintenance in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.